论文部分内容阅读
Phase Ⅲ non-inferiority study of cabazitaxel(C)20 mg/m2(C20)versus 25 mg/m2(C25)in patients(pts)with
【作 者】
：
【机 构】
：
The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research,London,United Kingdom
【出 处】
：
2016年临床肿瘤学新进展学术研讨会
【发表日期】
：
2016年5期
其他文献
A randomized phase Ⅲ trial between adjuvant docetaxel and surveillance after radical prostatectomy f
会议
Quality of life(QOL)analysis from CHAARTED:Chemohormonal androgen ablation randomized trial in prost
会议
A randomized trial of a shorter radiation fractionation schedule for the treatment of localized pros
会议
Overall survival(OS)in METEOR,a randomized phase 3 trial of cabozantinib(Cabo)versus everolimus(Eve)
会议
Atezolizumab(atezo)as first-line(1L)therapy in cisplatin-ineligible locally advanced/metastatic urot
会议
Limited versus extended pelvic lymphadenectomy in patients with bladder cancer undergoing radical cy
会议
OV21/PETROC:A randomized Gynecologic Cancer Intergroup(GCIG)phase Ⅱ study of intraperitoneal(IP)vers
会议
Baseline quality of life(QOL)as a predictor of stopping chemotherapy early,and of overall survival,i
会议